MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms
with genetic data.
Magnetic resonance imaging of benign soft tissue neoplasms
They detail the principles and practice of biopsy diagnosis and management of these lesions, ancillary techniques for the evaluation and diagnosis of bone and soft tissue neoplasms
, spindle cell tumors in children and adults, giant cell tumors, myxoid lesions, lipomatous tumors, vascular tumors, pleomorphic sarcomas, osseous tumors, cartilaginous neoplasms, small round cell neoplasms, epithelioid and polygonal cell tumors, and cystic lesions, and their clinical, cytologic and histologic, and radiographic features and differential diagnosis, with clinical vignettes.
MDM2 and CDK4 immuno-stainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms
with genetic data.
1 The differential diagnosis of sacral chordoma includes soft tissue neoplasms
(ie, osteosarcoma) that involve expansile masses in the pelvis, chondroid chordoma, and, in males, prostatic carcinoma.
In the thorax, FDG PET is used to (a) evaluate solitary pulmonary nodules and other suspicious opacities, (b) stage lung cancer, (c) assess response to treatment of malignancy, (d) detect recurrence of malignancy, (e) evaluate soft tissue neoplasms, and (f) identify malignant pleural disease.
PET has been applied to the evaluation of suspected malignant pleural disease and soft tissue neoplasms.
More than any other subspecialty within pathology, with the exception of perhaps hematopathology, molecular studies have become important in the diagnosis of soft tissue neoplasms.
To examine patterns of use of FISH in the diagnosis of soft tissue neoplasms, and to evaluate the utility of the method, we reviewed 230 consecutive soft tissue cases where FISH was performed.
Standard stains used in the diagnosis of soft tissue neoplasms
are listed in Table 2.
10,56) Second, EMA expression in soft tissue neoplasms
is not restricted to perineuriomas; it can be detected in neoplasms with (myo)fibroblastic differentiation as well as in synovial sarcomas, in epithelioid sarcomas, (26,42,57) and in other mesenchymal neoplasms.
The introductory section presents a concise summary of soft tissue tumors, including pathologic and clinical data for the optimal management of soft tissue neoplasms